DIVO was created on 2016-12-14 by Amplify. The fund's investment portfolio concentrates primarily on large cap equity. The ETF currently has 3621.63m in AUM and 29 holdings. DIVO is an actively managed ETF that provides income by selecting stocks from the S&P 500 Index overlaid with a tactical call writing strategy.
Current Value
$41.601 Year Return
Current Value
$41.601 Year Return
Assets Under Management
$3.74B
Div Yield %
4.45%
P/E Ratio
21.91
Net Asset Value
$41.59
Expense Ratio
0.56%
1Y ETF Return
0.24%
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
BRK.B | 62.91% | $1.01T | +29.88% | 0.00% |
AXP | 62.26% | $201.15B | +75.95% | 0.94% |
CNI | 57.10% | $67.10B | -6.77% | 2.29% |
TXT | 56.89% | $15.08B | +4.50% | 0.10% |
GWW | 56.52% | $57.08B | +45.28% | 0.68% |
MA | 55.56% | $476.78B | +27.02% | 0.51% |
SPGI | 55.30% | $155.87B | +21.40% | 0.72% |
CSCO | 54.18% | $227.24B | +19.27% | 2.80% |
V | 54.07% | $595.29B | +23.64% | 0.69% |
WEX | 53.29% | $7.10B | +2.88% | 0.00% |
CTAS | 52.31% | $87.91B | +57.60% | 2.14% |
PCAR | 52.17% | $57.87B | +24.80% | 1.06% |
BR | 51.78% | $26.28B | +21.37% | 1.47% |
CVX | 51.71% | $286.82B | +10.80% | 4.08% |
DE | 51.63% | $109.46B | +4.56% | 1.45% |
IBM | 50.31% | $194.41B | +36.61% | 3.16% |
HON | 49.99% | $148.39B | +19.33% | 1.92% |
VRSN | 49.05% | $17.13B | -16.16% | 0.00% |
NDAQ | 48.46% | $46.07B | +46.76% | 1.14% |
HES | 47.79% | $45.06B | +1.32% | 1.24% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
SYPR | 0.10% | $32.23M | -26.32% | 0.00% |
LQDA | 0.10% | $859.91M | +53.94% | 0.00% |
IMNN | -0.32% | $10.02M | -22.89% | 0.00% |
PRPO | -0.49% | $9.10M | -13.65% | 0.00% |
EDR | -0.55% | $9.01B | +19.26% | 0.82% |
MCK | 0.57% | $78.15B | +35.51% | 0.42% |
INSM | -0.65% | $13.19B | +202.50% | 0.00% |
RLMD | 0.77% | $89.92M | +1.36% | 0.00% |
PRPH | 0.81% | $18.14M | -82.61% | 0.00% |
FATBB | -0.83% | $81.94M | -12.91% | 11.69% |
CYD | -0.87% | $364.46M | -2.94% | 4.26% |
TCTM | 0.90% | $8.10M | -42.99% | 0.00% |
QXO | 0.91% | $6.51B | -35.95% | 0.00% |
NEUE | 0.95% | $40.93M | -34.13% | 0.00% |
UUU | 1.20% | $4.97M | -41.89% | 0.00% |
OXBR | 1.20% | $19.05M | +178.18% | 0.00% |
CTMX | -1.33% | $69.86M | -31.59% | 0.00% |
VIRT | 1.39% | $3.17B | +110.38% | 2.60% |
BTCT | 1.54% | $42.61M | +353.33% | 0.00% |
PULM | -1.88% | $19.83M | +202.98% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
HUSA | -8.90% | $16.69M | -11.56% | 0.00% |
QTTB | -7.46% | $354.34M | +188.64% | 0.00% |
BACK | -3.20% | $1.76M | -32.90% | 0.00% |
STG | -3.10% | $35.67M | +7.92% | 0.00% |
GPCR | -2.20% | $1.88B | -36.14% | 0.00% |
CBOE | -2.02% | $21.46B | +15.84% | 1.11% |
TPST | -1.99% | $37.75M | -77.59% | 0.00% |
PULM | -1.88% | $19.83M | +202.98% | 0.00% |
CTMX | -1.33% | $69.86M | -31.59% | 0.00% |
CYD | -0.87% | $364.46M | -2.94% | 4.26% |
FATBB | -0.83% | $81.94M | -12.91% | 11.69% |
INSM | -0.65% | $13.19B | +202.50% | 0.00% |
EDR | -0.55% | $9.01B | +19.26% | 0.82% |
PRPO | -0.49% | $9.10M | -13.65% | 0.00% |
IMNN | -0.32% | $10.02M | -22.89% | 0.00% |
SYPR | 0.10% | $32.23M | -26.32% | 0.00% |
LQDA | 0.10% | $859.91M | +53.94% | 0.00% |
MCK | 0.57% | $78.15B | +35.51% | 0.42% |
RLMD | 0.77% | $89.92M | +1.36% | 0.00% |
PRPH | 0.81% | $18.14M | -82.61% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
DGRO | 93.14% | $30.46B | 0.08% |
DLN | 92.64% | $4.41B | 0.28% |
MGV | 92.39% | $8.48B | 0.07% |
DIA | 92.15% | $38.06B | 0.16% |
VTV | 92.03% | $131.67B | 0.04% |
DTD | 91.98% | $1.36B | 0.28% |
VIG | 91.53% | $87.09B | 0.06% |
PRF | 91.21% | $7.59B | 0.39% |
VYM | 90.91% | $60.55B | 0.06% |
IWX | 90.60% | $2.42B | 0.2% |
RWL | 90.29% | $4.09B | 0.39% |
SCHV | 90.02% | $12.04B | 0.04% |
SPYV | 89.91% | $24.94B | 0.04% |
IVE | 89.86% | $36.17B | 0.18% |
VOOV | 89.86% | $5.36B | 0.1% |
IUSV | 89.82% | $19.83B | 0.04% |
TDVG | 88.97% | $841.99M | 0.5% |
DIVB | 88.48% | $573.13M | 0.05% |
PY | 88.43% | $78.15M | 0.15% |
IUS | 88.42% | $619.68M | 0.19% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
UNG | 0.03% | $908.80M | 1.06% |
IVOL | -0.17% | $548.70M | 1.02% |
XHLF | 1.32% | $874.27M | 0.03% |
BILZ | 1.51% | $563.02M | 0.14% |
JBBB | 1.60% | $1.26B | 0.49% |
KCCA | 2.15% | $220.51M | 0.87% |
BOXX | 2.23% | $4.43B | 0.1949% |
KRBN | 2.26% | $242.47M | 0.85% |
XONE | 2.79% | $548.88M | 0.03% |
XBIL | 3.28% | $637.70M | 0.15% |
SHYD | 3.38% | $311.50M | 0.35% |
KMLM | -3.46% | $353.87M | 0.9% |
HIGH | -3.62% | $302.78M | 0.51% |
CLOI | -3.77% | $715.40M | 0.4% |
CORN | -4.05% | $61.12M | 0.2% |
YEAR | 4.07% | $1.13B | 0.25% |
DFNM | -4.28% | $1.40B | 0.17% |
WEAT | -4.43% | $120.27M | 0.28% |
IBTE | -4.57% | $1.70B | 0.07% |
HDRO | -4.68% | $164.26M | 0.3% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -58.17% | $195.31M | 0.85% |
TAIL | -47.84% | $67.98M | 0.59% |
BTAL | -41.13% | $388.04M | 1.43% |
USDU | -27.62% | $201.97M | 0.5% |
UUP | -18.00% | $309.25M | 0.77% |
CTA | -13.06% | $350.27M | 0.78% |
JUCY | -7.86% | $324.29M | 0.6% |
EQLS | -5.15% | $76.08M | 1% |
HDRO | -4.68% | $164.26M | 0.3% |
IBTE | -4.57% | $1.70B | 0.07% |
WEAT | -4.43% | $120.27M | 0.28% |
DFNM | -4.28% | $1.40B | 0.17% |
CORN | -4.05% | $61.12M | 0.2% |
CLOI | -3.77% | $715.40M | 0.4% |
HIGH | -3.62% | $302.78M | 0.51% |
KMLM | -3.46% | $353.87M | 0.9% |
IVOL | -0.17% | $548.70M | 1.02% |
UNG | 0.03% | $908.80M | 1.06% |
XHLF | 1.32% | $874.27M | 0.03% |
BILZ | 1.51% | $563.02M | 0.14% |
Yahoo
CHICAGO, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Amplify ETFs announces October income distributions for its income ETFs. ETF NameTickerAmount per ShareEx-DateRecord DatePayable DateAmplify Samsung SOFR ETFSOFR$0.4047510/30/2410/30/2410/31/24Amplify Cash Flow High Income ETFHCOW$0.1724010/30/2410/30/2410/31/24Amplify CWP Enhanced Dividend Income ETFDIVO$0.1641910/30/2410/30/2410/31/24Amplify CWP International Enhanced Dividend Income ETFIDVO$0.1560910/30/2410/30/2410/31/24Amplify CWP Growth & Income E
SeekingAlpha
DIVO's tactical covered call strategy offers a balance of income and appreciation. Read why DIVO ETF's positions could do well in 2025.
Yahoo
AIVC emerges from Amplify’s acquisition of ETF Managers Group.
Yahoo
CHICAGO, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Amplify ETFs announces September income distributions for its Income ETFs. ETF NameTickerAmount per ShareEx-DateRecord DatePayable DateAmplify Samsung SOFR ETFSOFR$0.427339/27/20249/27/20249/30/2024Amplify CWP Enhanced Dividend Income ETFDIVO$0.163439/27/20249/27/20249/30/2024Amplify Cash Flow High Income ETFHCOW$0.160009/27/20249/27/20249/30/2024Amplify CWP International Enhanced Dividend Income ETFIDVO$0.155209/27/20249/27/20249/30/2024Amplify CWP Gr
SeekingAlpha
DIVO invests in high-quality U.S. equities and sells covered calls on some of its holdings. Read why I think the fund is an incredibly well-rounded investment.
Yahoo
With two tech-fueled market sell-offs occurring within the last month, volatility (^VIX) can be a concern for many investors who are hoping for stability in their portfolios. Amplify ETFs Founder and CEO Christian Magoon joins Wealth! to give insight into which ETFs can help during times of volatility. Magoon advises clients to re-examine "core equity positions" in "this volatile period in the fall." September is historically a tough month for both equity markets (^DJI, ^IXIC, ^GSPC) and bitcoin (BTC-USD) in the crypto space. "And instead of maybe going just 100% long, looking at a high-quality covered call equity strategy, that would give you kind of the benefit of higher quality names, but then also the ability to have covered call income from those names," Magoon says, "which acts as a hedge during kind of downward market environments, and also kind of benefits in terms of more option income as markets become more volatile." Magoon elaborates on a potential avenue for investors looking to hop on to the weight-loss drug craze: "We launched the first ETF that tracks this GLP-1 weight loss drug category. That's the Amplify drug Weight Loss Drug and Treatment ETF (THNR)... So it's... the only index based ETF to track this segment that owns the companies that are manufacturing GLP-1s and that are in clinical trials on the GLP-1 side. In addition, it owns some of the enablers of this technology. The companies that are making the injection pens, doing the testing, or third party manufacturing of the drug." For more expert insight and the latest market action, click here to watch this full episode of Wealth! This post was written by Nicholas Jacobino
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.